Search Results - "Kagoo, Toshiya"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
  2. 2

    Discordant lymphoma of diffuse large B-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified in a human T-cell leukemia virus type-I carrier by Sumiya, Chieko, Kagoo, Toshiya, Yokoyama, Akihiro, Yano, Takahiro, Ueno, Hironori

    Published in Rinshō ketsueki (2021)
    “…A 69-year-old man was diagnosed with diffuse large B-cell lymphoma (DLBCL) negative for Epstein-Barr virus-encoded small nuclear RNA 1 (EBER-1) in October…”
    Get more information
    Journal Article
  3. 3

    Bridging-to-transplant with Azacitidine for Myelodysplastic Syndrome and Acute Myeloid Leukemia, Reduces the Incidence of Acute Graft- versus -host Disease by Murakami, Koichi, Ueno, Hironori, Okabe, Takashi, Kagoo, Toshiya, Boku, Saigen, Yano, Takahiro, Yokoyama, Akihiro

    Published in Hematology reports (15-06-2017)
    “…Allogeneic stem cell transplantation (allo-SCT) is the only curative option for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Azacitidine…”
    Get full text
    Journal Article
  4. 4

    Occurrence of acquired factor V inhibitor during antibiotic therapy for a surgical wound infection by Okabe, Takashi, Ueno, Hironori, Fujita, Shinya, Kagoo, Toshiya, Boku, Saigen, Yano, Takahiro, Yokoyama, Akihiro

    Published in Rinshō ketsueki (2018)
    “…Acquired factor V (FV) inhibitor is a rare disorder. Herein we report a case of an 82-year-old Japanese woman with FV inhibitor exhibiting a pseudo decline in…”
    Get more information
    Journal Article
  5. 5
  6. 6

    Rapid improvement of fluid retention with lenalidomide plus low-dose dexamethasone for POEMS syndrome relapsed after autologous peripheral blood stem cell transplantation by Ohashi, Kota, Yokoyama, Akihiro, Kagoo, Toshiya, Hosoda, Toru, Yamamoto, Ryusuke, Yoneda, Mie, Kudo, Masahisa, Boku, Saigen, Ueno, Hironori, Yano, Takahiro

    Published in Rinshō ketsueki (01-07-2013)
    “…We report a 53-year-old male with POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome who relapsed after…”
    Get more information
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Safety and Effectiveness of Ixazomib Dose-escalating Strategy in Ixazomib-Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma by OHASHI, YASUKATA, YATABE, MEGUMI, NIIJIMA, DAISUKE, TANI, KENTARO, OGAWA, CHIAKI, YACHI, YUTAKA, KAGOO, TOSHIYA, BOKU, SAIGEN, UENO, HIRONORI, YANO, TAKAHIRO, HIGAI, KOJI, YOKOYAMA, AKIHIRO

    Published in In vivo (Athens) (01-09-2020)
    “…BACKGROUND/AIMGastrointestinal toxicity is common in patients receiving common therapy of ixazomib with lenalidomide and low-dose dexamethasone (IRd) for…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16